eXoZymes, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
EXOZ Nasdaq 2836 www.exozymes.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for eXoZymes, Inc.

eXoZymes Achieves 100× Scale-up of NCT Production Using Exozymes, Demonstrating Near-perfect Feedstock Conversion - Dec 11th, 2025 2:10 pm
EXoZymes Inc (EXOZ) Q3 2025 Earnings Call Highlights: Unlocking Market Opportunities Amid ... - Nov 13th, 2025 10:07 pm
eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today - Nov 13th, 2025 2:30 pm
eXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of Staff - Nov 13th, 2025 2:15 pm
eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST - Nov 10th, 2025 3:00 pm
CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference - Oct 30th, 2025 2:10 pm
CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference - Oct 29th, 2025 3:40 pm
CEO of eXoZymes to Present at ThinkEquity's Annual Investor Conference - Oct 23rd, 2025 2:50 pm
eXoZymes Inc. Partners With B2i Digital to Spotlight the Cell-Free Next Generation of Biomanufacturing - Oct 14th, 2025 4:58 pm
Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees - Sep 30th, 2025 2:10 pm
Wall Street Set to Open Higher Wednesday as Key Inflation Measure Declines - Sep 10th, 2025 7:26 am
Positive week for eXoZymes, Inc. (NASDAQ:EXOZ) institutional investors who control 48% of the company - Sep 8th, 2025 4:02 am
eXoZymes Provides Second Quarter 2025 Update at 5PM EST Today - Aug 12th, 2025 2:50 pm
eXoZymes to Host Second Quarter 2025 Update on Tuesday August 12, 2025, at 5PM EST - Aug 7th, 2025 4:35 pm
eXoZymes Details Biomanufacturing Breakthrough: 4 Grams of NCT with Over 99% Purity - Jul 29th, 2025 5:57 am
eXoZymes Biomanufacturing Breakthrough: From Concept to Gram-Scale NCT in Only 5 Months - Jul 22nd, 2025 2:10 pm
Here's Why We're Watching eXoZymes' (NASDAQ:EXOZ) Cash Burn Situation - Jul 2nd, 2025 6:31 am
eXoZymes Selected as Core Industry Partner in $9M NSF-Funded Initiative to Advance Modular Cell-Free Biomanufacturing - Jun 26th, 2025 2:10 pm
eXoZymes Highlights Scalable Biomanufacturing Platform and First Spinout, NCTx, on Grow Everything Podcast - May 16th, 2025 7:25 am
eXoZymes Provides First Quarter 2025 and NCTx Subsidiary Update at 5PM EST Today - May 12th, 2025 2:10 pm